Mis Siete Reinos Por Algo Así

deje de pelearse con su cuerpo porque la única persona que va a salir perdiendo es usted

Me, and the Leprechaun and what happened in the clouds.

I met a Leprechaun at the rainbow’s end, he was sitting on his pot of gold, all dressed in a green, and golden blend, he looked so sad; not brave and bold. I snatched the gold from beneath his arse, I was sure he would scream and rave, I was dreaming of champaigne and cars, But he stopped me dead, with the sobs he made.  I sat beside him on the fluffy cloud, and I asked him what was troubling him, he wiped his tears, then spoke aloud, and the tale he told, was sad and grim. Mrs Leprechaun, had been gone for days, he had searched for her,and he feared the worst, it was not like her; she had settled ways, now he blamed her missing, on the Goblin’s curse. “ Come on “, says I, “ we’ll find your love, I’ll not  leave your side ‘til she’s safe back home “,  and we walked for miles on the clouds above, until the sun, no longer shone. He magic’d  up a jug of grog, it was hot as lava; it burned like hell, when from out of the swirling, misty fog, a booming voice, his name did yell. She knocked the hat from off his head, she tore gold buttons, from his shirt of green, she said she thought that he was dead, while all this time, he drank poteen*. I left them to their argument, and went off to find some place to sleep, I dreamed of gold that was heaven sent, but for that gold, I did not weep. * poteen: Irish moonshine.   Ambrose Harte    Scattered Thoughts  

Hay que abrir los ojos del alma y desatarlo de definiciones banales, que nos llevan a pensar que es un sentimiento de una sola forma y que va en una sola dirección porque yo lo he visto desde el sur, y también lo he sentido en el vaivén de las olas. Yo lo he notado en la mirada de agradecimiento de alguien y en las lágrimas de quien echa de menos. He encontrado el amor en distintas maneras y sé que aún me faltan muchísimas más por descubrir.

M. Sierra VIllanueva

ay Dio mio

The Miseducation of Cameron Post (2018)

“25 de enero 2017 No me puedo ir a dormir sin decirte que alegras mi vida a cada momento… Luz de mis días. Qué jamás me falte tu risa perfecta, la paz de tu mirada, tus cálidas manos, la forma de tu boca, tu andar distraído, tus piernas delgadas, tu cabello rebelde, la música de tu voz… Debes saber que eres lo más bello que existe y que es hermoso poder mirarte, tocarte, refugiarme en tus brazos cuando hay miedo… Te quiero, te quieren mis huesos, mi carne, mi alma, mi mente, mi corazón… No te vayas ésta noche, no te vayas nunca… Quiero verte cada día al despertar”

— Letras Secretas (via letrassecretas)

“Trata de no pensar mucho las cosas, todo va a estar bien.”

— SuspirosAlAire

Ja ja ja ja ja

I have two moods: Nothing matters, and everything matters too much.

LAZY SUNDAYS WOTH HARRY PLS

He used to be the type to wake up early during the weekends so he could get everything done by the late afternoon and have an evening with a couple of his mates, but things changed when he met you.

He became the type to wake up later than usual (still managing to be wide awake before you roused from your much needed sleep) and hold you close to his lanky frame. An arm wrapped around your upper body as he lay beside you, his hot breath hitting your cheek and though he once swore he admired being the little spoon, he loved being the big spoon with you.

There was just something about having the ability to keep you within arms reach, body entangled in yours. To keep you near and think about how lucky he was. How lucky he was that you hadn’t done a runner once he asked you to be his (or at first glance) because as sappy as he sounds, he hasn’t felt love like this before and he can’t believe he’s managed to snag you - at least that’s what his mother says.

“G'morning,” Harry pronounces with a rough sleep drawl, although he’s been awake for twenty minutes now. He scratches his shirt clad chest with his index finger and uses his head to gesture to the plate on the table. “Made you breakfast.”

Seguir leyendo

Study Looks for DNA Changes to Measure Parkinson’s Disease

Neurons derived from a patient with Parkinson’s disease. Courtesy of Regis Grailhe, Nasia Antoniou and Rebecca Matsas, Institut Pasteur Korea/Nikon Small World.

Researchers at University of California San Diego School of Medicine and Arizona State University (ASU) have received funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson’s disease (PD), which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.

“The exact cause of Parkinson’s is unknown, but evidence points to a combination of genetic and environmental factors. Right now, there is no objective test or biomarker for PD, which increases the risk of misdiagnosis and delayed treatment,” said Paula Desplats, PhD, assistant professor in the Department of Neurosciences at UC San Diego School of Medicine and co-principal investigator of the new study with Travis Dunckley, PhD, assistant research professor at ASU’s Biodesign Institute.

The new study will analyze nearly 2,500 blood samples collected longitudinally over three years in the MJFF-sponsored Parkinson’s Progression Markers Initiative (PPMI). These samples include donations from patients diagnosed with idiopathic (cause unknown) PD; PD patients and asymptomatic individuals who carry a genetic mutation in the PD-implicated LRKK2 gene; at-risk populations of people with REM sleep behavior disorder and/or smell loss; as well as healthy control subjects. Researchers will analyze DNA methylation, an epigenetic modification of the DNA that can change genetic activity without changing the underlying sequence. DNA methylation is critical to turning genes on and off and affects a vast range of cellular functions and fundamental development.

“This epigenetic analysis could help us better understand the pathology of Parkinson’s disease, pointing to biomarker candidates and, potentially, novel therapeutic targets,” said Samantha Hutten, PhD, MJFF senior associate director of research partnerships. “In addition, this DNA methylation data grows the value of the PPMI clinical, imaging and biological database, the most robust in Parkinson’s research.”

“Study Looks for DNA Changes to Measure Parkinson’s Disease“